Home/Filings/4/0001415889-25-008500
4//SEC Filing

Liawatidewi Yakob 4

Accession 0001415889-25-008500

CIK 0001297184other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 6:41 PM ET

Size

7.2 KB

Accession

0001415889-25-008500

Insider Transaction Report

Form 4
Period: 2025-03-15
Liawatidewi Yakob
DirectorEVP CORP ADMIN CENTER
Transactions
  • Tax Payment

    Common Stock

    2025-03-15$26.66/sh1,031$27,48692,640 total
  • Tax Payment

    Common Stock

    2025-03-17$27.69/sh1,731$47,93190,909 total
Holdings
  • Common Stock

    (indirect: See footnote)
    2,459
Footnotes (2)
  • [F1]The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs.
  • [F2]The reported shares are held of record by the Yakob and Sunmoon Trust dated July 25, 2013 for which the reporting person serves as a trustee.

Issuer

Amphastar Pharmaceuticals, Inc.

CIK 0001297184

Entity typeother

Related Parties

1
  • filerCIK 0001743927

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 6:41 PM ET
Size
7.2 KB